Alhagi pseudalhagi (Bieb.) Desv.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | A. camelorum Fisch. ex DC. A. maurorum Medic. |
| Family | Papilionaceae; Fabaceae. |
| Habitat | The drier parts of Rajasthan, Gujarat, Punjab and Uttar Pradesh. |
| English | Camel Thorn, Persian Manna Plant. |
| Ayurvedic | Yavaasaka, Yavaasa, Yaasa, Duhsparshaa, Duraalabhaa, Kunaashak. Substitute for Dhanvayaasa. Yaasa-sharkaraa (Alhagi-manna). |
| Unani | Jawaansaa. Turanjabeen (Alhagi-manna). |
| Siddha / Tamil | Punaikanjuri, Kanchori. |
| Action | Laxative, antibilious, diuretic, diaphoretic, expectorant. Leaves—used for fever, headache, rheumatism. Flowers—blood coagulant, used for piles. Alhagimanna—expectorant, antiemetic, laxative. |
| Dosage | Whole plant—20–50 g for decoction. (API Vol. II.) Decoction—50–100 ml. (CCRAS.) |
| Taxonomic Cohort | Genus Alhagi (1 documented species); Family Papilionaceae (67 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Alhagi pseudalhagi (taxonomically cited with authority (Bieb.) Desv.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Papilionaceae; Fabaceae (primary family classification: Papilionaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy A. camelorum Fisch. ex DC. A. maurorum Medic, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: The drier parts of Rajasthan, Gujarat, Punjab and Uttar Pradesh.
Across classical and vernacular Indian systems of medicine, Alhagi pseudalhagi is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Camel Thorn, Persian Manna Plant; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Yavaasaka, Yavaasa, Yaasa, Duhsparshaa, Duraalabhaa, Kunaashak. Substitute for Dhanvayaasa. Yaasa-sharkaraa (Alhagi-manna); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Jawaansaa. Turanjabeen (Alhagi-manna); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Punaikanjuri, Kanchori. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Alhagi pseudalhagi are: Laxative, antibilious, diuretic, diaphoretic, expectorant. Leaves—used for fever, headache, rheumatism. Flowers—blood coagulant, used for piles. Alhagimanna—expectorant, antiemetic, laxative. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Alhagi pseudalhagi establish the following evidence base: Along with other therapeutic applications, The Ayurvedic Pharmacopoeia of India indicates the use of dried whole plant in gout and haemorrhagic disorders. The aerial parts contain flavonoids, tannins, sterols, triterpenes, saponins and anthroquinones. The proanthocyanidins derived from the plant possess hypolipidemic and antiatherosclerotic properties. The compounds prevented an increase in rat serum cholesterol and triglycerides, and they decreased the manifestation of atherosclerosis. A polymeric proanthocyanidin, extracted from the plant, improved energy metabolism and increased the work capacity in rats. Ethanolic extract of the aerial parts produced positive inotropic effect on rabbit heart.

Botanical Reference 1: Alhagi — Botanical specimen

Botanical Reference 2: Alhagi — Botanical specimen

Botanical Reference 3: Alhagi pseudalhagi — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Alhagi pseudalhagi stands as a distinct representative of the genus Alhagi. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Papilionaceae encompasses 67 documented medicinal species (3.69% of the 1,814-species flora). Other representative medicinal members of Papilionaceae include: Abrus precatorius Linn. (Gunjaa), Arachis hypogaea (Mandapi), Atylosia goensis (Maashaparni), Atylosia scarabaeoides (Vana-kulattha), Butea monosperma (Paalasha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 67 medicinal species of family Papilionaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Alhagi pseudalhagi are prescribed as follows: Whole plant—20–50 g for decoction. (API Vol. II.) Decoction—50–100 ml. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Alhagi pseudalhagi integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.